Back to Search Start Over

Interest of pharmacoepidemiology for the study of antibiotic drugs

Authors :
Agnès Sommet
Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
Source :
Thérapie, Thérapie, EDP Sciences, 2019, 74, pp.249-253. ⟨10.1016/j.therap.2018.10.005⟩
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Abstract

Antibiotics (ABs) exposure of population is known as the main driving force for the emergence and spread of bacterial resistance in the community. Pharmacoepidemiology is the study of interactions between drugs and human populations, investigating, in real conditions of life, benefits, risks and use of drugs. Thus, pharmacoepidemiology is particularly of interest to monitor ABs use in both hospital and community settings. This can help to better understanding determinants of ABs use and to evaluate their impact. ABs use can also be a marker of an infection, which can be an ADR of other drugs. The development of pharmacoepidemiology should improve the "rational use" of ABs.

Details

ISSN :
00405957 and 19585578
Volume :
74
Database :
OpenAIRE
Journal :
Therapies
Accession number :
edsair.doi.dedup.....4d834d0e16a94fd218ecfcbdbbe04174
Full Text :
https://doi.org/10.1016/j.therap.2018.10.005